SCSatyadeo Choubey

Satyadeo Choubey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Satyadeo Choubey has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Concurrent tropical pulmonary eosinophilia and allergic bronchopulmonary aspergillosis in asthma: a prospective observational study from a filariasis-endemic region

    by Md Arshad Ejazi, Satyadeo Choubey, Manish Shankar, Thanisk R, Priyanka Choudhury

    Tropical pulmonary eosinophilia (TPE) and allergic bronchopulmonary aspergillosis (ABPA) share cough, wheeze, eosinophilia, and marked immunoglobulin (Ig) E elevation and may coexist in patients with asthma in filariasis-endemic settings. We prospectively characterized this overlap phenotype at a tertiary respiratory center in eastern India. Eligible patients older than 10 years had a documented prior physician diagnosis of asthma and, at presentation, an absolute eosinophil count (AEC) >1000 cells/µL and total IgE >1000 IU/mL; all underwent evaluation for both TPE and ABPA. These laboratory thresholds were study-entry criteria and were not substituted for disease-specific diagnostic definitions. TPE attribution required a compatible clinic-serological profile and a study-defined post-diethylcarbamazine (DEC) haematological response of at least 50% reduction in AEC. For the present analysis, ABPA was classified according to the revised 2024 International Society for Human and Animal Mycology criteria using prospectively collected clinical, immunological, and imaging variables. In TPE-compatible patients, DEC was given before ABPA-directed therapy to preserve interpretation of the eosinophilic response. Among 312 prospectively evaluated patients, 132 met the study definitions for TPE-ABPA overlap, 77 for TPE alone, and 103 for ABPA alone. In the overlap cohort, mean age was 36.2±15.9 years; median baseline AEC was 6071 cells/µL [interquartile range (IQR) 3793-11,000] and median total IgE was 7641 IU/mL (IQR 4525-13,621). Aspergillus fumigatus-specific IgE and IgG were positive in all 132; the filarial antigen was positive in 128 (97.0%), and there was qualitative filarial IgG in all 132. The dominant recorded high-resolution computed tomography pattern was normal in 73 (55.3%), while bronchiectasis was recorded in 42 (31.8%). All overlap patients received DEC and fulfilled the study-defined ≥50% AEC response criterion. ABPA-directed treatment comprised systemic corticosteroids alone in 71 (53.8%), itraconazole alone in 41 (31.1%), and both in 20 (15.2%). Concurrent TPE and ABPA should be considered in endemic regions when asthma is accompanied by disproportionate eosinophilia and IgE elevation; recognition of one eosinophilic disorder should not prematurely terminate evaluation for the other.

    • 4 February 2026
      • Vol. 66  (5) , 1924-1934
    Open Access

    Comparative efficacy and complications of Transthoracic Ultrasound guided Pleural biopsy versus Medical thoracoscopic Pleural biopsy in Undiagnosed Exudative Pleural Effusion: Experience from a Tertiary Care Institute of Eastern India.

    by Arshad Ejazi, Satyadeo Choubey, Thanisk R, Manish Shankar, Priyanka Choudhury

    Approximately 20% of exudative pleural effusions remain undiagnosed even after diagnostic thoracentesis. In such situations, pleural biopsy is essential for establishing a diagnosis. Pleural biopsy can be obtained either through invasive procedures, such as medical or surgical thoracoscopy, or through semi-invasive techniques, such as closed pleural biopsy, with or without image guidance. This study compared the efficacy and complications of transthoracic ultrasound-guided versus medical thoracoscopic pleural biopsy for undiagnosed exudative pleural effusion. This prospective observational comparative study included 110 patients who were randomly assigned to undergo either ultrasound-guided pleural biopsy (UPB) or medical thoracoscopic pleural biopsy (TPB) under local anesthesia. The specimens were sent for histopathological examination (HPE) and GeneXpert for Mycobacterium tuberculosis (CBNAAT). Conclusive diagnosis was achieved in 96% of TPB cases and 95% of UPB cases. Malignancy predominated in TPB (56%), whereas tuberculosis in UPB (47%). Among the tuberculosis cases, CBNAAT was positive in 18 UPB and 12 TPB cases, with two rifampicin-resistant cases in each group. The mean hospital stay was longer in TPB (11.3 days) than in UPB (1.5 days), and complications were fewer in UPB. Both UPB and TPB can be used in undiagnosed pleural effusion cases. Although TPB is the gold standard for diagnosing pleural diseases, UPB is a less invasive, relatively safer, and simpler procedure.

  • Open Access

    Diagnostic utility of various gross thoracoscopic appearances in tuberculous pleural effusion and their correlation with microbiological and histopathological findings – a hospital-based prospective observational cross-sectional study

    by R Thanisk, Arshad Ejazi, Satyadeo Choubey, Manish Shankar, Rakesh Kumar, Bipin Kumar

    Background: Tuberculous pleural effusion (TPE) is a significant global health problem, particularly in high-prevalence regions such as India. Early diagnosis is crucial for effective treatment of this condition. Medical thoracoscopy offers a superior diagnostic yield compared with traditional methods. This study aimed to evaluate various thoracoscopic appearances in TPE, their diagnostic utility, and their correlation with microbiological and histopathological findings. Materials and Methods: This hospital-based prospective observational cross-sectional study was conducted at a tertiary care teaching hospital in eastern India, from 2023 to 2024. One hundred and twenty-one patients with suspected TPE underwent thoracoscopy, and the findings were classified into 11 categories. Pleural biopsies were examined, and the data were analyzed. Results: One hundred and three patients were confirmed to have TPE. The most common thoracoscopic findings were easily peelable pleura and adhesions. Significant associations ( P <0.05) were found between thoracoscopic findings of pustules and positive Cartridge-Based Nucleic Acid Amplification Test results, as well as between easily peelable pleura, multiple variable-sized nodules, and positive mycobacterial culture. Pustules, sago grain nodules, and a few discrete nodules were the most specific findings, with a high positive predictive value. Normal-looking pleura were also observed in TPE. Easily peelable and hard-to-peel pleura were novel findings in our study. Conclusion: Medical thoracoscopy is a valuable diagnostic tool for TPE exhibiting various gross pleural appearances, and targeted biopsy of various lesions increases the yield of microbiological and histopathological analyses. Findings such as pustules, sago grain nodules, and a few discrete nodules are highly specific for TPE, allowing for the early initiation of antitubercular therapy even before microbiological confirmation.


  • Disseminated cryptococcosis presenting as lung mass

    by Manish Shankar, Satyadeo Choubey, Arshad Ejazi, R Thanisk

    Cryptococcosis is an opportunistic fungal infection in immunocompromised individuals, with a disease spectrum ranging from asymptomatic pulmonary infection to fatal meningoencephalitis. This case report describes the case of a man with diabetes in his late 40s who presented with chest pain and generalised weakness. Contrast-enhanced CT of the chest revealed a mass lesion in the left upper lobe. Ultrasound-guided biopsy of the mass revealed a diagnosis of cryptococcosis. Cerebrospinal fluid and blood samples tested positive for cryptococcal antigens. A final diagnosis of disseminated cryptococcosis was made, and the patient was started on liposomal amphotericin B and oral fluconazole. The patient showed clinical and radiological improvement. This case highlights the fact that not all pulmonary masses are necessarily malignant. Hence, it is essential to consider non-malignant causes, particularly cryptococcosis, in immunocompromised individuals.

  • Open Access

    Clinico-Hematological Profile of COVID-19 Patients: A Perspective of the Indian Scenario

    by Iffat Jamal, Shuchi Smita, Ravi Bhushan Raman, Vijayanand Choudhary, Satyadeo Choubey, Kaushal Kumar

    Background and objectives: The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2, a newly emergent coronavirus, first recognized in Wuhan, China in December 2019. Early identification of laboratory indicators helps in distinguishing severe patients from mild to moderate counterparts and can facilitate medical interventions, thereby lowering ...